India's drug landscape is witnessing a remarkable rise in active ingredient production houses. Fueled by increasing global requirement and favorable government regulations, the nation’s API manufacturing industry has emerged as a key contributor to the international healthcare system. This growth is creating numerous opportunities for funding and